This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klaman, L. D. Articles by Thorley-Lawson, D. A. Search for Related Content PubMed PubMed Citation Articles by Klaman, L. D. Articles by Thorley-Lawson, D. A.

 Previous Article  |  Next Article 

J. Virol., 02 1995, 871-881, Vol 69, No. 2
Copyright © 1995, American Society for Microbiology

Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site

LD Klaman and DA Thorley-Lawson
Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111.

Epstein-Barr virus (EBV) infection of mature, resting B cells drives them to become lymphoblasts expressing high levels of cell surface molecules, such as CD48, characteristically expressed on normal activated B cells. Here, we report on the identification of an enhancer element in the CD48 gene which reproducibly confers strong transcriptional activity only in EBV-positive B-lymphoblastoid cell lines. The element is not activated upon infection of established EBV- negative B-cell lines, indicating that EBV fails to drive these cells to a fully lymphoblastoid phenotype. An NF-kappa B binding site is an essential component of the element but alone is not sufficient to account for the activity or the specificity of the element. We have detected a specific nuclear protein complex that binds to the element and show that NF-kappa B1 (p50) is a part of this complex. The EBV- encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle.

This article has been cited by other articles:

• Bloch-Queyrat, C., Fondaneche, M.-C., Chen, R., Yin, L., Relouzat, F., Veillette, A., Fischer, A., Latour, S. (2005). Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J. Exp. Med. 202: 181-192 [Abstract] [Full Text]  
• Carter, K. L., Cahir-McFarland, E., Kieff, E. (2002). Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression. J. Virol. 76: 10427-10436 [Abstract] [Full Text]  
• Ianelli, C. J., DeLellis, R., Thorley-Lawson, D. A. (1998). CD48 Binds to Heparan Sulfate on the Surface of Epithelial Cells. J. Biol. Chem. 273: 23367-23375 [Abstract] [Full Text]  
• Brodeur, S. R., Cheng, G., Baltimore, D., Thorley-Lawson, D. A. (1997). Localization of the Major NF-kappa B-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs. J. Biol. Chem. 272: 19777-19784 [Abstract] [Full Text]